Just the Facts

Share This Page

Opioid Use, Abuse and Misuse Resource Center

APhA works closely to monitor, respond and inform our members about opioid use, abuse, and misuse. This site will be updated with new information and resources as they become available.

Achieving a Proper Balance

APhA believes it is imperative that a proper balance be maintained in delivering appropriate pain management for the millions of patients with legitimate needs for controlled substances while taking steps to minimize inappropriate use and abuse.  Pharmacists possess unique knowledge about the safe and effective use of medications and about the adverse events resulting from inappropriate use. Such knowledge enables pharmacists to play an important role in patient access to opioids, but also opioid drug abuse prevention, education, and assistance.  


Interactive tools and recent publications that can be used regularly or referenced to help pharmacists treat patients using opioids. Includes CDC's opioid prescribing guideline (released March 15), a buprenorphine treatment physician locator, Medicare Part D opioid mapping tool, and more!

Newly added December 2016: CDC Opioid Guide Mobile App







A compilation of guidelines and resources to help pharmacist decision-making and improve communication with patients, such as clinical guidelines for the use of buprenorphine, warning signs related to prescribing and dispensing controlled substances, and medicines recommended for disposal by flushing. 

Newly added March 2017:  Naloxone Supplement (Journal of the American Pharmacists Association)





State and federal resources that includes news and government issued materials related to opioids, such as The Surgeon General's Report on Alcohol, Drugs, and Health - Facing Addiction in America, and information regarding state prescription drug monitoring programs. 






A collection of training, webinars, and learning archives, including Pathways to Safer Opioid Use, an immersive, interactive training tool designed using opioid-related recommendations. Other resources discuss topics such as abuse deterrent formulations, care of patients with addiction, naloxone, and the role of pharmacy in opioid therapeutics.  Continuing education credit is available for some of the trainings listed. 

Newly added March 2017: Prescribetoprevent.org







Looking for ways to get involved? This section highlights opportunities for pharmacists and pharmacy technicians to connect with other professionals and to learn more about the U.S. Surgeon General's latest call to action regarding opioids.   







Various articles and research that discuss trends in prescription drug abuse, effectiveness and risks opioid treatment, abuse-deterrent formulations, buprenorphine and more!


December 21, 2016
December 21, 2016
On December 20, DEA released a notice that clarifies DEA’s renewal process. The December 20 notice is a welcome change for pharmacists because DEA’s...
DEA will maintain grace periods and other policies regarding registration renewals
December 16, 2016
December 16, 2016
DEA has released a notice that could have serious implications for pharmacists, prescribers, researchers, manufacturers, distributors, and others...
DEA will end grace periods and adopt tougher policies to renew controlled substance registrations
November 17, 2016
November 17, 2016
A first-ever Surgeon General’s Report on Alcohol, Drugs, and Health launched on November 17 gives health care providers, policy makers, law...
Report on alcohol, drugs, and health released today

Please contact Jenna Ventresca (jventresca@aphanet.org) with any comments, concerns, or suggested content.